Suppression of ovarian function by a combined oral contraceptive containing 0.02 mg ethinyl estradiol and 2 mg chlormadinone acetate given in a 24/4-day.

Slides:

Advertisements

Similar presentations

The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization: a systematic review and meta-analysis

Advertisements

Low-dose aspirin in non-tubal IVF patients with previous failed conception: a prospective randomized double-blind placebo-controlled trial Marieke J.

Hysterosalpingo-foam sonography, a less painful procedure for tubal patency testing during fertility workup compared with (serial) hysterosalpingography:

Outdoor air pollution and human infertility: a systematic review

Wendy S. Vitek, M. D. , Jeannine Witmyer, Ph. D. , Sandra A. Carson, M

Is the type of gonadotropin-releasing hormone suppression protocol for ovarian hyperstimulation associated with ectopic pregnancy in fresh autologous.

Daily physical activity and hot flashes in the Study of Women's Health Across the Nation (SWAN) Flashes Study Carolyn Gibson, M.P.H., M.S., Karen Matthews,

Karl R. Hansen, M. D. , Ph. D. , George M. Hodnett, M. D

Bjørn Bay, M. D. , Erik Lykke Mortensen, M. Sc

Michael M. Alper, M.D. Fertility and Sterility

Mike Ripley, M. D. , F. R. C. S. C. , Andrea Lanes, M. Sc

Janet Kwee, M. D. , Roel Schats, M. D. , Ph. D. , Joseph McDonnell, M

Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm.

Rene Ecochard, M. D. , Ph. D. , Thomas Bouchard, M. D. , Rene Leiva, M

Growth rates of ovarian follicles during natural menstrual cycles, oral contraception cycles, and ovarian stimulation cycles Angela R. Baerwald, Ph.D.,

Cem Atabekoglu, M. D. , Murat Sonmezer, M. D. , Sinan Özkavukcu, M. D

Medical treatment of ectopic pregnancy: a committee opinion

Follicle-stimulating hormone administered at the time of human chorionic gonadotropin trigger improves oocyte developmental competence in in vitro fertilization.

Evaluation of an ultra-low-dose oral contraceptive for dysmenorrhea: a placebo- controlled, double-blind, randomized trial Tasuku Harada, M.D., Mikio.

Grant D.E. McWilliams, D.O., John L. Frattarelli, M.D.

Hysterosalpingo-foam sonography, a less painful procedure for tubal patency testing during fertility workup compared with (serial) hysterosalpingography:

Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization Ginny Mounce,

A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data

Improved monofollicular ovulation in anovulatory or oligo-ovulatory women after a low- dose step-up protocol with weekly increments of 25 international.

Randomized comparison of different ovarian stimulation regimens for assisted reproductive technology in baboons (Papio anubis) Atunga Nyachieo, M.Sc.,

Letrozole versus combined metformin and clomiphene citrate for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a randomized.

Intraoperative and postoperative lower genital tract changes after global endometrial ablation using the Hydro ThermAblator® device Martin Farrugia,

Angela R. Baerwald, Ph. D. , Olufemi A. Olatunbosun, M. D. , Roger A

Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 μg) and ethinyl estradiol (15 μg) on ovarian activity Helen Sullivan,

Hysteroscopic local anesthetic intrauterine cornual block in office endometrial ablation: a randomized controlled trial Vinod Kumar, Ph.D., Konstantinos.

Mieke Carine Wim Eeckhaut, Ph.D. Fertility and Sterility

Looking back: egg donors' retrospective evaluations of their motivations, expectations, and experiences during their first donation cycle Nancy J. Kenney,

Reliability of automated volumetric measurement of multiple growing follicles in controlled ovarian hyperstimulation Frederic Lamazou, M.D., Elisangela.

Katherine D. LaGuardia, M. D. , M. P. H. , Alan C. Fisher, Dr. P. H

The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization: a systematic review and meta-analysis

A randomized clinical trial of endometrial perfusion with granulocyte colony-stimulating factor in in vitro fertilization cycles: impact on endometrial.

Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in vitro fertilization/intracytoplasmic.

Robotic-assisted laparoscopic ovarian tissue transplantation

Cervical mucus status can be accurately estimated by transvaginal ultrasound during fertility evaluation Igal Wolman, M.D., Tamar Birenbaum Gal, M.D.,

Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles Karin.

Fertility and Sterility

Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D.

Effect of letrozole at 2. 5 mg or 5

The forgotten coil Fertility and Sterility

M. Kathleen Clark, Ph. D. , MaryFran R. Sowers, Ph. D

CDB-2914, a novel selective progesterone receptor modulator, differentially regulates endometrial gene expression in the proliferative phase of the menstrual.

Prospective cohort study of three- versus two-dimensional ultrasound for prediction of oocyte maturity Doron Shmorgun, M.D., Edward Hughes, M.D., Patrick.

GnRH antagonists may affect endometrial receptivity

P-425 Fertility and Sterility Volume 86, Issue 3, (September 2006)

Cameron Gilbert, M. Sc. , Maria Valois, M. D. , FRCPC, Ph. D

Heterotopic autotransplantation of cryobanked human ovarian tissue as a strategy to restore ovarian function S.Samuel Kim, M.D., In-Tak Hwang, M.D.,

L. Scott, J. Bernsten, K. DeLegge, J. Hill, N. Ramsing

Fertility and Sterility: an evaluation

Sedigheh Borna, M.D., Azita Nasery, M.D. Fertility and Sterility

Impact of subclinical hypothyroidism in women with recurrent early pregnancy loss Lia A. Bernardi, M.D., Ronald N. Cohen, M.D., Mary D. Stephenson, M.D.,

Counteraction during movement of spermatozoa by Trichomonas vaginalis observed by visual image analysis: a possible cause of female infertility Viroj.

Use of Utrogestan during controlled ovarian hyperstimulation in normally ovulating women undergoing in vitro fertilization or intracytoplasmic sperm injection.

Janet S. Carpenter, Ph. D. , R. N. , Katherine A. Guthrie, Ph. D

Current evaluation of amenorrhea

A woman with premature ovarian failure induced by Tripterygium wilfordii Hook.f. gives birth to a healthy child Xin Chen, M.D., M.Sc., Shi-ling Chen,

Fertility and Sterility

Follicular fluid of single follicles from women with PCOS contains higher levels of müllerian inhibiting substance L.T. Ku, S.T. Nakajima, M.E. McClure,

David H. Barad, M.D., M.S., Norbert Gleicher, M.D.

In vitro sildenafil citrate use as a sperm motility stimulant

Bárbara Oriol, M. D. , Ana Barrio, M. D. , Alberto Pacheco, Ph. D

Fertility after discontinuation of treatment with an oral contraceptive containing 30 μg of ethinyl estradiol and 2 mg of dienogest Inka Wiegratz, Ph.D.,

Daniel R. Grow, M.D., Khosro Iromloo, M.D. Fertility and Sterility

Ovarian follicular volume and follicular surface area are better indicators of follicular growth and maturation, respectively, than is follicular diameter

A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for.

Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization Ginny Mounce,

Presentation transcript:

Suppression of ovarian function by a combined oral contraceptive containing 0.02 mg ethinyl estradiol and 2 mg chlormadinone acetate given in a 24/4-day intake regimen over three cycles Jürgen Spona, Ph.D., Natascha Binder, Ph.D., Kornelia Höschen, M.Sc., Wilfried Feichtinger, Ph.D. Fertility and Sterility Volume 94, Issue 4, Pages 1195-1201 (September 2010) DOI: 10.1016/j.fertnstert.2009.06.057 Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions

Figure 1 CONSORT diagram: subjects included in the trial. Fertility and Sterility 2010 94, 1195-1201DOI: (10.1016/j.fertnstert.2009.06.057) Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions

Figure 2 Follicle-like structure size, cervical reaction score, and endometrial thickness (per protocol set; median [quartile 1/quartile 3] time course). For follicle-like structure size, values recorded as “<10 mm” are replaced by 10 mm in calculations of quartiles. Solid blue line = median course; upper red dashed line = the third quartile; lower red dashed line = the first quartile. Fertility and Sterility 2010 94, 1195-1201DOI: (10.1016/j.fertnstert.2009.06.057) Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions